Issue 1, 2019
From the journal:

MedChemComm

Correction: Benzoflavone derivatives as potent antihyperuricemic agents

Jatinder V. Singh,a   Gurbachan Mal,a   Gurleen Kaur,a   Manish K. Gupta,b   Amrit Pal Singh,a   Kunal Nepali,a   Harbinder Singh,*a   Sahil Sharma*a  and  Preet Mohinder S. Bedi*a  

* Corresponding authors

a Department of Pharmaceutical Sciences, Guru Nanak Dev University, Amritsar, Punjab 143005, India
E-mail: singh.harbinder40@gmail.com

b TERI-Deakin Nanobiotechnology Centre, The Energy and Resources Institute, TERI Gram, Gual Pahari, Gurugram, Haryana 122001, India

Abstract

Correction for ‘Benzoflavone derivatives as potent antihyperuricemic agents’ by Jatinder V. Singh et al., MedChemCommun, 2019, DOI: 10.1039/c8md00512e.

About
Cited by
Related
Download options Please wait...

Associated articles

Article information

DOI
https://doi.org/10.1039/C9MD90002K
Article type
Correction
Submitted
10 Jan 2019
Accepted
10 Jan 2019
First published
15 Jan 2019
This article is Open Access
Creative Commons BY license

Med. Chem. Commun., 2019,10, 182-182

Permissions

Request permissions

Correction: Benzoflavone derivatives as potent antihyperuricemic agents

J. V. Singh, G. Mal, G. Kaur, M. K. Gupta, A. P. Singh, K. Nepali, H. Singh, S. Sharma and P. M. S. Bedi, Med. Chem. Commun., 2019, 10, 182 DOI: 10.1039/C9MD90002K

This article is licensed under a Creative Commons Attribution 3.0 Unported Licence. You can use material from this article in other publications without requesting further permissions from the RSC, provided that the correct acknowledgement is given.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements